This federal contract award, valued at $80,606.37, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to procure a live cell imaging system. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. The contract does not involve any set-aside designation.
Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, and has a strong presence in the federal contracting space, particularly in supporting agencies involved in life sciences research, disease prevention, and healthcare. The company has been awarded multiple contracts and sub-awards from various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), and Department of Justice, to supply specialized products, services, and consumables for applications such as DNA sequencing, gene expression analysis, protein analysis, and molecular diagnostics.
Generated 4/2/25, 8:25 PM